CHEST Thoracic Oncology & Chest Procedures
@CHESTOncology
Followers
965
Following
469
Media
148
Statuses
386
Multidisciplinary care and clinical practice in the areas of interventional procedures, lung cancer, pleural disease, and ultrasound/chest imaging.
Joined July 2020
With #CHEST2023 starting in a few days, you'll want to adjust your sleep routines. Looking forward to seeing everyone at the Networks Mixer, Mon., Oct. 9, 4 – 5 pm HST, Hawaiʻi Convention Center, Children’s Courtyard, 3rd Floor. #CHESTOncology #CHESTSleep.
Help your circadian rhythms align to Hawaiʻi Standard Time (HST) so you can get the most out of your #CHEST2023 experience. Read more from your #CHESTSleep Network.
0
1
1
Not long to go! Register now for all things lung cancer and pleural disease at CHEST 2023!
0
1
1
Interesting real-world data on ICI associated pneumonitis (incidence of ≥Grade2, 9.5%, nearly half of patient's lung injury did not completely resolve) : checkout the paper for full details.
Hot off the press from #MDAPulmonary #ICI in #LungCancer those with #ILD .increased risk for #irAE.@ajaysheshadri @MehmetAltanMD @sfaiz212 @ANaingMD @MDAndersonNews @atstoa @CHESTOncology @OncJournal .
0
2
3
Come say hi, check out our booth and be in with a chance to win some cool prizes #ATS2023 @accpchest
0
4
15
RT @DTownsendCHEST: Want to get involved in @accpchest Leadership? CHEST Networks have almost 100 open positions this cycle. Deadline is Ju….
0
8
0
Want to get involved in @accpchest Leadership? The CHEST Thoracic Oncology & Chest Procedures Network has 23 open positions this cycle!! Deadline to apply is June 5, don't miss out!
0
5
5
Check out the NCI’s priorities for cancer, including support for cancer screening in the recently published National Cancer Plan. Download the full text here
0
0
0
Using plasma proteins to assess lung cancer risk in lung nodules, check out the research here.
A support vector machine algorithm accurately reclassified some patients into low-risk and very high-risk categories, suggesting the potential to improve pulmonary nodule risk assessment. Read the original research in the April @journal_CHEST issue: #MedEd
0
0
1
The updated USPSTF guideline has lowered the age for eligibility. Vigilance is needed to ensure we continue to address current and future disparities as we include younger patient groups.
0
0
1
CDR was 0.56%, half that of NLST. Cancers with known stage had similar distribution to NLST: Stage I (53.5%), II (12.7%), III (19.6%), IV (14.3%).
1
0
0
17.3% had a positive baseline scan. LUNG RADS score works well in detecting cancer: Lung-RADS 3 (0.4%), 4A (2.6%), 4B (11.1%), 4X (19.9%). <4% of cancers were detected after a negative baseline scan (Lung RADS 1-2).
1
0
0
Adherence: low, only 22.3% at T1 (11-15 months after baseline scan). Familiar patterns seen by race and geography aOR: 0.84 Black people, 0.73 Hispanic people, 0.79 Asian people. People living in Western and Southern US less likely to be screened than North-East (0.71 and 0.65).
1
0
0
Real world outcomes from the first 1 million people screened in over 3,000 facilities: let’s take a look at some of the findings
1
4
21
RT @accpchest: Share your research findings on a big scale at #CHEST2023. Submit your abstracts and case reports on emerging medicine and c….
0
5
0
RT @accpchest: Read the article below to find out what other factors are associated with attempts to quit smoking among pts who undergo #Lu….
0
6
0
RT @accpchest: How does a lung CA prediction neural network perform compared with current standard of care workup? Read the full original r….
0
2
0
RT @journal_CHEST: What is the effect of an immediate telephone smoking cessation intervention on quit rates? Read the full original resear….
0
1
0
A nice blog post by one of our own IP docs @PCubedMD on lung cancer screening!.
Some Patients Fear Lung Cancer Screenings. Here’s Why They Shouldn’t. @InovaSchar @InovaHealth @CHESTOncology @AAB_IP
0
0
0